Literature DB >> 15872369

Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH.

Michael Lassmann, Heribert Hänscheid, Christoph Reiners, Stephen R Thomas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15872369

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  3 in total

1.  Application of a whole-body pharmacokinetic model for targeted radionuclide therapy to NM404 and FLT.

Authors:  Joseph J Grudzinski; John M Floberg; Sarah R Mudd; Justin J Jeffery; Eric T Peterson; Alice Nomura; Ronald R Burnette; Wolfgang A Tomé; Jamey P Weichert; Robert Jeraj
Journal:  Phys Med Biol       Date:  2012-03-07       Impact factor: 3.609

2.  Dosimetric effectiveness of targeted radionuclide therapy based on a pharmacokinetic landscape.

Authors:  Joseph J Grudzinski; Ronald R Burnette; Jamey P Weichert; Robert Jeraj
Journal:  Cancer Biother Radiopharm       Date:  2010-08       Impact factor: 3.099

3.  The biological effectiveness of targeted radionuclide therapy based on a whole-body pharmacokinetic model.

Authors:  Joseph J Grudzinski; Wolfgang Tomé; Jamey P Weichert; Robert Jeraj
Journal:  Phys Med Biol       Date:  2010-09-08       Impact factor: 3.609

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.